Dirtan Tablet 160 mg (Valsartan)
Valsartan 160mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
MFDS item code 201503910 · Approved 2015.06.16
This product's status changed to Expired on 2025.06.16. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of hypertension and heart failure; reduction of the risk of death after myocardial infarction
This medication is used for essential hypertension and heart failure, particularly in heart failure patients who are intolerant to ACE inhibitors. It also helps to reduce the risk of death in patients with left ventricular dysfunction or systolic dysfunction after myocardial infarction. Thus, it is effectively used for hypertension management, heart failure treatment, and prevention of complications after myocardial infarction.
1. Essential hypertension Take with water during or between meals. It is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). 1) Adults: The recommended oral dose is valsartan 80 mg once daily, regardless of sex or race. The blood pressure-lowering effect develops gradually within 2 weeks and reaches its maximum after 4 weeks. For patients whose blood pressure is not adequately controlled, the dose may be increased to 160 mg daily or a diuretic may be added. If further blood pressure reduction is needed, the dose may be increased up to a maximum of 320 mg daily. 2) Older adults (aged 75 years or older): Start treatment with 40 mg of this medicine once daily. 3) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No dose adjustment is required. (2) Creatinine clearance 10 ∼ 20 mL/min: Start treatment with 40 mg of this medicine once daily. (3) Creatinine clearance less than 10 mL/min and patients undergoing dialysis: Do not administer this medicine. 4) Patients with volume depletion: In patients with volume depletion (e.g., patients taking high-dose diuretics whose dose cannot be reduced), start treatment with 40 mg of this medicine once daily. 5) Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, start treatment with 40 mg of this medicine once daily; the dose should not exceed 80 mg daily. Do not administer this medicine to patients with severe hepatic impairment, cirrhosis, or cholestasis. 2. Heart failure Adults: The recommended starting dose is 40 mg orally twice daily. The dose may be increased to 80 mg or 160 mg per dose. When coadministered with a diuretic, consider reducing the diuretic dose. The maximum daily dose is 320 mg, administered in divided doses. Triple therapy with this medicine, an ACE inhibitor, and a beta-blocker is not recommended. 3. Reduction of the risk of death after myocardial infarction Adults: Treatment may be initiated within 12 hours of the onset of myocardial infarction. The recommended starting dose is 20 mg twice daily. Over the following several weeks, increase the dose according to the patient's tolerability to 40 mg, 80 mg, and 160 mg per dose twice daily. Consider dose reduction if hypotension or renal failure occurs. This medicine may also be administered to patients receiving other treatments after myocardial infarction (e.g., thrombolytics, acetylsalicylic acid, beta-blockers, and statins). However, concomitant use with an ACE inhibitor is not recommended. 4. Patients with renal impairment: No dose adjustment is required for creatinine clearance of 10 mL/min or higher. However, do not administer this medicine to patients with creatinine clearance less than 10 mL/min or patients undergoing dialysis, as there is no experience with its use in these patients. 5. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of this medicine should preferably not exceed 80 mg. If administering 80 mg or more daily, consider whether the benefits of increasing the dose outweigh the risks. Do not administer this medicine to patients with severe hepatic impairment, cirrhosis, or cholestasis.
Children and adolescents under 18 years of age: Safety and efficacy have not been established. Children and adolescents under 18 years of age: Safety and efficacy have not been established.
This medication can cause serious harm to the fetus, especially during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Women who are allergic to this medication, pregnant or breastfeeding, patients with severely impaired liver or kidney function, and patients with certain hereditary angioedema should not take this medication. Elderly patients, patients with hyperkalemia, patients with mildly impaired liver function, and patients with heart valve disease or myocardial disease should take this medication with caution, ensuring that blood pressure does not drop too low. When taking this medication, side effects like dizziness, fatigue, cough, and diarrhea may occur, and rarely severe allergic reactions, renal dysfunction, or blood abnormalities can happen; therefore, upon occurrence of these symptoms, it is essential to consult a physician immediately. In particular, patients with heart failure or post-myocardial infarction should take this medication while periodically checking renal function and blood pressure, and caution is required as the risk of side effects may increase when combined with other antihypertensive medications or certain diuretics. This medication can increase potassium levels, so if taken with potassium supplements or drugs high in potassium, monitoring blood potassium levels closely is necessary. Women who are pregnant or may become pregnant should not take this medication, and breastfeeding should be avoided or breastfeeding should be discontinued if taking this medication. Safety and efficacy in pediatric patients and adolescents under 18 years of age have not been established; therefore it is advisable not to use.
Headache
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air and moisture, in a cool place below 30 degrees Celsius. This will help maintain the medication's effectiveness and prevent degradation.
Oval, film-coated tablet with an orange color tinged with gray
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Valsartan 160mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Valsartan 80mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.

Valsartan 160mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.

Valsartan 40mg
Tablet · Prescription medication
Samsung Novartis Co., Ltd.
Valsartan
Prescription medication
Korea Sandos Co., Ltd.
Valsartan
Prescription medication
Korea Sandos Co., Ltd.

Valsartan
Prescription medication
Korea Sandos Co., Ltd.

Valsartan 320mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.